期刊文献+

荧光原位杂交技术检测乳腺癌HER-2基因扩增实验方法的比较 被引量:9

Experimental comparison of fluorescence in situ hybridization in breast cancer HER-2 gene detection
原文传递
导出
摘要 目的:探讨荧光原位杂交(FISH)技术检测乳腺癌HER-2基因的最佳实验方法。方法:应用FISH技术检测55例乳腺癌组织标本的HER-2基因,分别采用水浴法和直接消化法,甲酰胺法和共变性法,检测HER-2基因表达成功率,对比实验方法的最佳结果。结果:两种消化法中,水浴法和直接法杂交成功率分别为86.21%(25/29)和88.46%(23/26),差异无统计学意义(P>0.05),杂信号比分别为17.24%(5/29)和46.15%(12/26),差异有统计学意义(P<0.05)。两种变性法中甲酰胺法和共变性法杂交成功率分别为73.08%(19/26)和93.10%(27/29),差异有统计学意义(P<0.05)。结论:FISH检测乳腺癌HER-2基因,以水浴法和共变性法杂交成功率最高。 OBJECTIVE: To investigate the optimal methods of fluorescence in situ hybrdization in HER-2 gene detection. METHOD: Totally 55 samples of breast cancer were gathered by bath and direct digestion, dimethyl- formamide and denaturation law, were compared by detecting the success expression rate of HER-2 gene. RESULTS: In two digest methods, the success rates of hybridization were 86.21%(25/29)and 88.46% (23/26), respectively and with no difference ( P 〉 0.05). But hybridization signal ratio were 17. 24%(5/29) and 46.15%(12/26), with significant difference(P〈0.05). In two digest methods, the success rates were 73.08% (19/26)and 93.10% (27/29), with significant difference(P 〈 0.05 ). CONCLUSION .. Detecting HER-2 gene by fluorescence in situ hybridization, bath and denaturation law hybridization variability have higher success rate.
作者 鲁萍 张谷
出处 《中华肿瘤防治杂志》 CAS 2011年第1期26-28,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 基因表达 原位杂交 荧光 breast neoplasms gene expression in stiu hybidization, fluorescence
  • 相关文献

参考文献6

  • 1Zeng X,Liang Z Y,Wu S P,et al. Analysis of Her-2 gene status in breast cancer with Her-2 protein overexpression[J]. Zhonghua Bing Li Xue Za Zhi,2006,35(10):584-588.
  • 2Ross J S, Gray G S. Targeted the rapy for cancer the HER2/neuand Herceptin story [J]. Clin Leadersh Manag Rev, 2003, 17:333-340.
  • 3Susanne Haas, Heidrun Gevensleben, Sylvia Rabstein, et al.Expression of heregulin, phosphorylated HER-2, HER-3 andHER-4 in HER-2 negative breast cancers[J]. Institute of Pathol-ogy,2009,21(2),299-304.
  • 4Wolff A C, Hammond M E,Schwartz J N, et al. American soei-ety of clinical oncology/college of american pathologists guidelinerecommendations for human epidermal growth factor receptor 2testing in breast cancer[J]. Arch Pathol Lab Med, 2007, 131(1):18-43.
  • 5Wang S, Hossein Saboorian M, Frenkel E P, et al. Aneusomy 17in breast cancer: its role in HER-2/neu protein expression andimplication for clinical assessment of HER-2/neu status[J]. ModPathol,2002,5(2):137-145.
  • 6Roche P C, Suman V J, Jenkins R B, et al. Concordance be-tween local and central laboratory HER2 testing in the breast in-tergroup trial N9831[J]. J Natl Cancer Inst,2002,94 : 855-857.

同被引文献81

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部